AIM ImmunoTech (AIM) Misses Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts AIM Hot Sheet
Price: $0.16 --0%
EPS Growth %: +90.4%
Financial Fact:
Gross profit: 2.47M
Today's EPS Names:
FUSE, INM, TRI, More
EPS Growth %: +90.4%
Financial Fact:
Gross profit: 2.47M
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
AIM ImmunoTech (NYSE: AIM) reported Q3 EPS of ($0.06).
For earnings history and earnings-related data on AIM ImmunoTech (AIM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Amdocs (DOX) Reports In-Line Q4 EPS
- trivago (TRVG) Misses Q3 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
